Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $461M (100.0% shares, 0.0% debt)

Holdings (42)

SPY SPDR S&P 500 ETF TR 49.0%
Value $226M Shares 500,000 Est. Cost Unrealized
XBI SPDR SER TR 5.9%
Value $26.96M Shares 300,000 Est. Cost Unrealized
ASND ASCENDIS PHARMA A/S 3.6%
Value $16.43M Shares 140,000 Est. Cost $131.68 Unrealized
COGT COGENT BIOSCIENCES INC 2.8%
Value $12.73M Shares 1,700,000 Est. Cost $10.34 Unrealized -32.7%
APLS APELLIS PHARMACEUTICALS INC 2.8%
Value $12.7M Shares 250,000 Est. Cost $49.72 Unrealized -11.2%
MERUS N V 2.3%
Value $10.58M Shares 400,000 Est. Cost $29.12 Unrealized
FOLD AMICUS THERAPEUTICS INC 2.3%
Value $10.42M Shares 1,100,000 Est. Cost $11.01 Unrealized -14.8%
SIERRA ONCOLOGY INC 2.3%
Value $10.42M Shares 325,000 Est. Cost $20.61 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 2.2%
Value $10.22M Shares 300,000 Est. Cost $28.96 Unrealized +10.4%
VRDN VIRIDIAN THERAPEUTICS INC 1.9%
Value $8.624M Shares 466,403 Est. Cost $18.53 Unrealized +3.7%
KARUNA THERAPEUTICS INC 1.7%
Value $7.607M Shares 60,000 Est. Cost $126.78 Unrealized
IVERIC BIO INC 1.6%
Value $7.574M Shares 450,000 Est. Cost $7.44 Unrealized
ARVN ARVINAS INC 1.6%
Value $7.403M Shares 110,000 Est. Cost $28.07 Unrealized +142.8%
PCVX VAXCYTE INC 1.6%
Value $7.245M Shares 300,000 Est. Cost $21.73 Unrealized +0.6%
KEZAR LIFE SCIENCES INC 1.4%
Value $6.648M Shares 400,000 Est. Cost $16.68 Unrealized
AXSM AXSOME THERAPEUTICS INC 1.3%
Value $6.209M Shares 150,000 Est. Cost $31.00 Unrealized 0.0%
CTI BIOPHARMA CORP 1.3%
Value $6.071M Shares 1,300,000 Est. Cost $2.98 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 1.2%
Value $5.691M Shares 350,000 Est. Cost $16.04 Unrealized 0.0%
RAPT THERAPEUTICS INC 1.2%
Value $5.498M Shares 250,000 Est. Cost $33.20 Unrealized
BCYC BICYCLE THERAPEUTICS PLC 1.0%
Value $4.388M Shares 100,000 Est. Cost $43.88 Unrealized
AXSM AXSOME THERAPEUTICS INC 0.8%
Value $3.911M Shares 94,500 Est. Cost $31.00 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 0.8%
Value $3.911M Shares 225,000 Est. Cost $18.21 Unrealized -7.5%
SRPT SAREPTA THERAPEUTICS INC 0.8%
Value $3.906M Shares 50,000 Est. Cost $85.49 Unrealized -10.4%
VERONA PHARMA PLC 0.8%
Value $3.743M Shares 750,000 Est. Cost $6.53 Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 0.8%
Value $3.691M Shares 80,000 Est. Cost $61.38 Unrealized -12.1%
DSGN DESIGN THERAPEUTICS INC 0.7%
Value $3.23M Shares 200,000 Est. Cost $16.57 Unrealized -7.5%
RCKT ROCKET PHARMACEUTICALS INC 0.7%
Value $3.172M Shares 200,000 Est. Cost $29.94 Unrealized -42.3%
XENE XENON PHARMACEUTICALS INC 0.7%
Value $3.057M Shares 100,000 Est. Cost $13.60 Unrealized +120.1%
RLMD RELMADA THERAPEUTICS INC 0.6%
Value $2.699M Shares 100,000 Est. Cost $26.77 Unrealized -22.7%
WHWK AADI BIOSCIENCE INC 0.6%
Value $2.546M Shares 150,000 Est. Cost $25.11 Unrealized -23.7%
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value $2.155M Shares 125,000 Est. Cost $6.81 Unrealized +100.4%
TARS TARSUS PHARMACEUTICALS INC 0.4%
Value $2.018M Shares 120,000 Est. Cost $31.23 Unrealized -40.6%
9 METERS BIOPHARMA INC 0.4%
Value $1.948M Shares 3,250,000 Est. Cost $1.25 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 0.4%
Value $1.866M Shares 85,000 Est. Cost $17.57 Unrealized +15.2%
SATSUMA PHARMACEUTICALS INC 0.4%
Value $1.8M Shares 473,562 Est. Cost $10.24 Unrealized
LEAP THERAPEUTICS INC 0.4%
Value $1.739M Shares 993,714 Est. Cost $4.01 Unrealized
MIRATI THERAPEUTICS INC 0.4%
Value $1.644M Shares 20,000 Est. Cost $98.34 Unrealized
VISTAGEN THERAPEUTICS INC 0.4%
Value $1.631M Shares 1,315,154 Est. Cost $2.02 Unrealized
AEGLEA BIOTHERAPEUTICS INC 0.3%
Value $1.579M Shares 686,599 Est. Cost $2.30 Unrealized
PARDES BIOSCIENCES INC 0.1%
Value $614K Shares 85,000 Est. Cost $12.61 Unrealized
LRMR LARIMAR THERAPEUTICS INC 0.1%
Value $405K Shares 100,000 Est. Cost $11.59 Unrealized -43.5%
PYXS PYXIS ONCOLOGY INC 0.1%
Value $303K Shares 75,000 Est. Cost $11.45 Unrealized -36.2%